Optimizing Outcomes in Venous Thromboembolism Among Hospitalized Medically Ill Patients Through an Integrated Risk Assessment Program

This publication was supported by Janssen Pharmaceuticals, Inc., and is intended for formulary decision makers, population health decision makers, and/or similar entities.

This AJMC^® Profiles in Care is an actionable resource for provider organizations seeking to implement a prevention protocol to reduce the incidence of preventable venous thromboembolism in hospitalized medically ill (nonsurgical) patients.